Just trying to get my bearings. I remember years ago we switched from lung to ovarian. Then ovarian was completed and we switched to various sarcomas. Then it seemed there was a backtrack to ovarian to get some more data or look at different targets or something.

Does anyone know when we will actually complete the computational work for ovarian? And then would we go back to finishing sarcoma, or is sarcoma computation completed? I remember discussion on next targets being pancreatic and maybe prostate, but my memory is fuzzy on the details.

Just trying to get clarity on the ovarian-sarcoma-ovarian situation. Thanks!